Contact Admin. Letermovir is a new antiviral compound with exclusive activity against human cytomegalovirus CMV. In contrast to nucleotide analogues, letermovir inhibits the packaging of the CMV genome into preformed virus capsids. Paediatric data are missing so far. Most users should sign in with their email address. If you originally registered with a username please use that to sign in. To purchase short term access, please sign in to your Oxford Academic account above.
Don't already have an Oxford Academic account? Oxford University Press is a department of the University of Oxford. It furthers the University's objective of excellence in research, scholarship, and education by publishing worldwide.
Sign In or Create an Account. Close mobile search navigation Article Navigation. Journal of Antimicrobial Chemotherapy , dkz, https: Sir, Letermovir is a new antiviral compound with exclusive activity against human cytomegalovirus CMV. For permissions, please email: You do not currently have access to this article. You could not be signed in.
Sign In Forgot password? Don't have an account? Sign in via your Institution Sign in. Purchase Subscription prices and ordering Short-term Access To purchase short term access, please sign in to your Oxford Academic account above.
This article is also available for rental through DeepDyve. Email alerts New issue alert. Receive exclusive offers and updates from Oxford Academic. Population pharmacokinetics of continuous-infusion ceftazidime in febrile neutropenic children undergoing HSCT: European guidelines for primary antifungal prophylaxis in adult haematology patients: Micafungin antifungal prophylaxis in children undergoing HSCT: Related articles in Google Scholar.
